October 14, 2019

Reata Announces Positive Topline Results from the MOXIe Registrational Trial of Omaveloxolone in Patients with Friedreich’s Ataxia

Click Below To Read Article

17806842-15615029782758005_origin.jpg

Get Connected!

  • Twitter Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon
  • Facebook Social Icon